Totally PLC Considers Subsidiary Sales Amid Strategic Review

The latest announcement is out from Totally ( (GB:TLY) ).

Totally PLC has announced that it has received several offers for its subsidiaries as part of a strategic review aimed at strengthening its balance sheet. The board of directors has determined that selling parts of the business is the only viable option to meet the Group’s liabilities in the near future. However, the potential proceeds from these sales are unlikely to cover all future liabilities, which may result in no value for ordinary shareholders.

The most recent analyst rating on (GB:TLY) stock is a Buy with a £0.20 price target. To see the full list of analyst forecasts on Totally stock, see the GB:TLY Stock Forecast page.

Spark’s Take on GB:TLY Stock

According to Spark, TipRanks’ AI Analyst, GB:TLY is a Neutral.

The overall stock score of GB:TLY is 53, indicating challenges primarily due to financial instability and valuation concerns. Significant risks stem from negative cash flows and inconsistent revenue. While technical indicators suggest bearish trends, insider confidence and recent contract renewals offer some potential for improvement.

To see Spark’s full report on GB:TLY stock, click here.

More about Totally

Totally is a prominent provider of healthcare and wellbeing services in the UK and Ireland, collaborating with the NHS and other healthcare providers to address the increasing demand for healthcare services. The company offers urgent care, elective care, and community dermatology clinics, as well as therapy services including physiotherapy and podiatry. Additionally, Totally provides corporate wellbeing services through Energy Fitness Professionals, managing workplace fitness and wellbeing programs.

Average Trading Volume: 2,227,716

Technical Sentiment Signal: Sell

Current Market Cap: £2.6M

For a thorough assessment of TLY stock, go to TipRanks’ Stock Analysis page.